About Shalaks Pharmaceuticals Pvt Ltd
Data last updated:
Shalaks Pharmaceuticals Pvt Ltd is a private limited company based in New Delhi, Delhi, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 November 1977.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1977PTC008799. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹4.2 Lakh. It is led by directors including Rajiv Dhingra and Pavan Kaul.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C3 Puja Housekaram Pura Commercial Center Milan Complex, New Delhi, Delhi, India – 110015.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.33 Lakh, a decline of 35% compared to the previous year. For the same year it recorded a net loss of ₹8.26 Lakh (net margin -88.6%) and EBITDA of -₹8.05 Lakh (EBITDA margin -86.3%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 4% over five years.
Court records list 3 cases involving the company, including 3 filed by the company. The company has 1 deal on record (1 acquisition); the latest was in November 2011.
The last known website on record is shalaks.com.
Company details
Contact details
Shalaks Pharmaceuticals Pvt Ltd's registered office is in New Delhi, Delhi. Its website is shalaks.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressC3 Puja Housekaram Pura Commercial Center Milan Complex, New Delhi, Delhi, India – 110015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Shalaks Pharmaceuticals Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Shalaks Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Shalaks Pharmaceuticals Pvt Ltd, buy the company report.
Financials of Shalaks Pharmaceuticals Pvt Ltd
FY 2024 filings availableShalaks Pharmaceuticals Pvt Ltd reported revenue of ₹9.33 Lakh (down 35% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 35% fall in the latest year. EBITDA fell 178% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹8.05 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -86.3% | ||||
| Net Profit Margin | -88.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shalaks Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Shalaks Pharmaceuticals Pvt Ltd
Shalaks Pharmaceuticals has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajiv Dhingra | Director | 04 Jan 2018 | 8 Years 10 Months | As last reported |
| Pavan Kaul | Director | 04 Jan 2018 | 8 Years 10 Months | As last reported |
| Roop Narain Gupta | Director | 01 Nov 1981 | 45 Years 0 Months | As last reported |
| Ashu Gupta Also directs: Avonmore Capital & Management Services Limited | Irp/Rp/Liquidator | 11 Feb 2025 | 1 Years 8 Months | As last reported |
Auditor
Shalaks Pharmaceuticals Pvt Ltd is audited by MOHINDRA ARORA & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MOHINDRA ARORA & CO | FY 2020 | 006551N |
Shareholding
The shareholding of Shalaks Pharmaceuticals Pvt Ltd is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Shalaks Pharmaceuticals Pvt Ltd, buy the company report.
Deals & funding
Shalaks Pharmaceuticals Pvt Ltd has 1 deal on record (1 acquisition); the latest was in November 2011.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2011 | Acquisition | ₹100.27 Cr | Buyer: Invida Holdings Pte. Ltd. Seller: Shalaks Pharmaceuticals Pvt Ltd |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Shalaks Pharmaceuticals Pvt Ltd has 3 court cases on record: 3 filed by Shalaks Pharmaceuticals. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (O.M.P.(I) (COMM.)) | Filed by the company against Tdi Infrastructure Limited & Ors. | Disposed |
| High Court of Delhi | Arbitration matter | Filed by the company against Tdi Infrastructure Ltd | Disposed |
| High Court of Delhi | Writ petition | Filed by the company against Union of India & Ors. | Disposed |
To see the full case history of Shalaks Pharmaceuticals Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shalaks Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Shalaks Pharmaceuticals Pvt Ltd has 1 active EPFO establishment as of Mar 27, 2024.
GST
Shalaks Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Shalaks Pharmaceuticals Pvt Ltd, buy the company report.
Recent activity
Shalaks Pharmaceuticals Pvt Ltd has 9 board changes on record since 1981: 4 appointments and 5 cessations. The latest: Ashu Gupta was appointed as Irp/Rp/Liquidator on 11 Feb 2025.
Frequently asked questions
Shalaks Pharmaceuticals is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Shalaks Pharmaceuticals is a company under liquidation, formerly operating as a private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 November 1977 and is registered under CIN U74899DL1977PTC008799. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Shalaks Pharmaceuticals has 4 current directors:
- Rajiv Dhingra - Director
- Pavan Kaul - Director
- Roop Narain Gupta - Director
- Ashu Gupta - Irp/Rp/Liquidator
The latest financial statements of Shalaks Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Shalaks Pharmaceuticals is U74899DL1977PTC008799. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shalaks Pharmaceuticals has 3 court cases on record: 3 filed by the company.
Shalaks Pharmaceuticals was incorporated on 30 November 1977. It is registered with the Registrar of Companies, Delhi.
Shalaks Pharmaceuticals has 1 deal on record (1 acquisition); the latest was in November 2011.
Ashu Gupta was appointed as Irp/Rp/Liquidator on 11 Feb 2025. Pavan Kaul was appointed as Director on 04 Jan 2018. Raj Kumar Wirmani ceased to be Managing Director on 04 Jan 2018. Shalaks Pharmaceuticals has 9 board changes on record in total.
Shalaks Pharmaceuticals can be reached through the website shalaks.com. Its registered office is in New Delhi, Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
